Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10462 |
Bavisant dihydrochloride
|
Others | Others |
Bavisant (JNJ-310010740) dihydrochloride is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition. | |||
T10462L |
Bavisant dihydrochloride hydrate
JNJ31001074AAC |
Others | Others |
Bavisant dihydrochloride hydrate (JNJ31001074AAC) is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD. in vivo: Mean change |